Fortress Biotech (FBIO) Given a $11.00 Price Target at HC Wainwright
The brokerage presently has a "buy" rating on the biopharmaceutical company's stock. HC Wainwright's target price would suggest a potential upside of 126.80% from the company's current price.
from Biotech News
0 Comments